Page last updated: 2024-10-24

chlorambucil and Spondylarthropathies

chlorambucil has been researched along with Spondylarthropathies in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Spondylarthropathies: Heterogeneous group of arthritic diseases sharing clinical and radiologic features. They are associated with the HLA-B27 ANTIGEN and some with a triggering infection. Most involve the axial joints in the SPINE, particularly the SACROILIAC JOINT, but can also involve asymmetric peripheral joints. Subsets include ANKYLOSING SPONDYLITIS; REACTIVE ARTHRITIS; PSORIATIC ARTHRITIS; and others.

Research Excerpts

ExcerptRelevanceReference
"Psoriatic spondyloarthropathy (PSA) can occasionally be complicated by AA amyloid, and renal amyloidosis should be suspected in patients with PSA who have unexplained proteinuria."1.32Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy. ( Hawkins, PN; Moots, RJ; Mpofu, S; Smith, PJ; Teh, LS, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mpofu, S1
Teh, LS1
Smith, PJ1
Moots, RJ1
Hawkins, PN1

Other Studies

1 other study available for chlorambucil and Spondylarthropathies

ArticleYear
Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy.
    Rheumatology (Oxford, England), 2003, Volume: 42, Issue:2

    Topics: Amyloidosis; Arthritis, Psoriatic; Chlorambucil; Follow-Up Studies; Humans; Kidney Diseases; Male; M

2003